HSA — authorised 13 June 2018
- Marketing authorisation holder: MDGH
- Status: likely_approved
HSA authorised Moxidectin on 13 June 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 13 June 2018.
MDGH holds the Singaporean marketing authorisation.